Karl Hoermann

929 total citations
37 papers, 713 citations indexed

About

Karl Hoermann is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Karl Hoermann has authored 37 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karl Hoermann's work include Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (5 papers) and Laser Applications in Dentistry and Medicine (5 papers). Karl Hoermann is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (5 papers) and Laser Applications in Dentistry and Medicine (5 papers). Karl Hoermann collaborates with scholars based in Germany, United States and China. Karl Hoermann's co-authors include Andreas E. Albers, Theresa L. Whiteside, Caroline Schaefer, Haneen Sadick, Ulrich Goessler, Alexander Sauter, Silke Gronau, Herbert Riechelmann, Gertraud Hanft and Frank Riedel and has published in prestigious journals such as Gastroenterology, British Journal of Cancer and Otolaryngology.

In The Last Decade

Karl Hoermann

35 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Hoermann Germany 12 315 231 200 108 87 37 713
Dipa Patel United States 9 256 0.8× 113 0.5× 362 1.8× 69 0.6× 110 1.3× 11 698
Alfred Schauer Germany 14 213 0.7× 133 0.6× 309 1.5× 107 1.0× 40 0.5× 22 683
Tatsushi Shiomi Japan 15 264 0.8× 147 0.6× 466 2.3× 55 0.5× 101 1.2× 45 893
Atte Kivisaari Finland 15 227 0.7× 224 1.0× 274 1.4× 119 1.1× 107 1.2× 20 792
Janine Soares Portugal 23 458 1.5× 105 0.5× 282 1.4× 59 0.5× 62 0.7× 49 1.2k
Thomas Möhler Germany 12 275 0.9× 198 0.9× 272 1.4× 71 0.7× 37 0.4× 23 597
Susanna Virolainen Finland 18 288 0.9× 80 0.3× 280 1.4× 55 0.5× 94 1.1× 25 730
Olivier Ramuz France 12 283 0.9× 170 0.7× 264 1.3× 24 0.2× 40 0.5× 21 594
Andrea G. M. Scholes United Kingdom 9 239 0.8× 64 0.3× 215 1.1× 27 0.3× 21 0.2× 10 586
Kirsten Smalley United States 11 404 1.3× 68 0.3× 624 3.1× 85 0.8× 48 0.6× 16 907

Countries citing papers authored by Karl Hoermann

Since Specialization
Citations

This map shows the geographic impact of Karl Hoermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Hoermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Hoermann more than expected).

Fields of papers citing papers by Karl Hoermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Hoermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Hoermann. The network helps show where Karl Hoermann may publish in the future.

Co-authorship network of co-authors of Karl Hoermann

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Hoermann. A scholar is included among the top collaborators of Karl Hoermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Hoermann. Karl Hoermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sommer, J. Ulrich, et al.. (2020). Cocaine Reduces Ciliary Beat Frequency of Human Nasal Epithelial Cells. In Vivo. 34(6). 3285–3289. 2 indexed citations
2.
Jungbauer, Frederic, et al.. (2017). Communicate or Die – A Model for HPV+ and HPV– CSCs and Their Interactions with SDF-1α. Anticancer Research. 37(9). 4827–4836. 4 indexed citations
4.
Sadick, Maliha, Christel Weiß, Sabine Frey, et al.. (2015). <sup>18</sup>F-Fluorodeoxyglucose Uptake Level-Based Lymph Node Staging in Oropharyngeal Squamous Cell Cancer - Role of Molecular Marker Expression on Diagnostic Outcome. Oncology Research and Treatment. 38(1-2). 16–22. 2 indexed citations
5.
Birk, Richard, et al.. (2015). Influence of static magnetic fields combined with human insulin-like growth factor 1 on human satellite cell cultures.. PubMed. 28(5). 795–802. 4 indexed citations
6.
Li, Chia‐Ying, et al.. (2014). Effect of Time-of-Flight Technique on the Diagnostic Performance of 18F-FDG PET/CT for Assessment of Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma. Journal of Nuclear Medicine Technology. 42(3). 181–187. 10 indexed citations
8.
Faber, Anne, et al.. (2013). Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.. PubMed. 33(6). 2457–65. 4 indexed citations
10.
Faber, Anne, et al.. (2013). SDF-1-CXCR4 axis: Cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma. Oncology Reports. 29(6). 2325–2331. 21 indexed citations
11.
Faber, Anne, Karl Hoermann, Jens Stern‐Straeter, David J. Schultz, & Ulrich Goessler. (2012). Functional effects of SDF-1α on a CD44+ CXCR4+ squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche. Oncology Reports. 29(2). 579–584. 18 indexed citations
13.
Riechelmann, Herbert, et al.. (2008). Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncology. 44(9). 823–829. 146 indexed citations
14.
Sadick, Haneen, et al.. (2008). Rhinophyma: Diagnosis and Treatment Options for a Disfiguring Tumor of the Nose. Annals of Plastic Surgery. 61(1). 114–120. 64 indexed citations
15.
Sadick, Haneen, Katrin Riedel, Gregor Bran, et al.. (2008). TGF-β1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. International Journal of Molecular Medicine. 22(1). 55–60. 29 indexed citations
16.
Sauter, Alexander, Charlotte Kloft, Silke Gronau, et al.. (2007). Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck. International Journal of Oncology. 30(4). 927–35. 50 indexed citations
17.
18.
Riedel, Frank, et al.. (2004). Human Chondrocytes Differentially Express Matrix Modulators during In‐Vitro Expansion. Otolaryngology. 131(2). 1 indexed citations
19.
Barton, Thomas, et al.. (1994). <title>New approach to determining laser effects on bone</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2327. 394–401. 1 indexed citations
20.
Barton, Thomas, et al.. (1994). <title>Possibilities and problems of using the holmium laser in ENT</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2128. 17–22. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026